How strongly tumor cells adhere to surrounding tissue could indicate how likely cancer will spread to other parts of the body, according to a new study led by bioengineers at the University of California San Diego. Using a spinning disc device, the researchers found that tumor cells that adhere weakly are more likely to migrate and invade other tissues compared with strongly adherent cells.
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego are running a Diabetes Intensive Medical Management (DIMM) “tune up” clinic for complex type 2 diabetes patients. In a study published in the March 2017 issue of the Journal of Managed Care & Specialty Pharmacy, the researchers report the clinic’s economic benefits, which include an estimated cost avoidance of $5,287 per DIMM clinic patient over three years.
Bioengineers at the University of California San Diego have developed a new tool to identify RNA-DNA interactions. The tool can provide a full account of all the RNA molecules that interact with a segment of DNA, as well as the locations of all these interactions — in just a single experiment. The research is a step toward identifying new functions and instructions encoded in the genome.
Researchers in earth sciences and information technology at UC San Diego are organizing a three-day Grand Challenges workshop May 31 to June 2 in La Jolla, Calif., on the topic of “Big Data and the Earth Sciences.”
A faculty chair in innovation and entrepreneurship at UC San Diego was created through the University of California’s Presidential Match for Endowed Chairs to recruit and retain top-flight faculty
As the current administration continues to call out perceived pitfalls of the North American Free Trade Agreement, or NAFTA, trade experts, business leaders, former government officials and current policymakers will gather at UC San Diego to lead timely and important conversations on the likely consequences of revoking or renegotiating the trade agreement.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
